株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

研究用抗体の世界市場予測 2022年:ウエスタンブロッティング・フローケミストリー・ELISA・免疫組織化学法・免疫蛍光法 (IF) ・免疫沈降法

Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 541252
出版日 ページ情報 英文 281 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
研究用抗体の世界市場予測 2022年:ウエスタンブロッティング・フローケミストリー・ELISA・免疫組織化学法・免疫蛍光法 (IF) ・免疫沈降法 Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022
出版日: 2017年08月07日 ページ情報: 英文 281 Pages
概要

研究用抗体 (試薬含む) の市場規模は、2017年から2022年にかけて6.2%のCAGR (年間複合成長率) で成長し、2017年の93億3,000万米ドルから2022年までに126億米ドルに達すると予測されています。ライフサイエンス産業におけるR&D活動・支出の増加、プロテオミクス研究&創薬への資金増加、および産学連携の増加は、予測期間中の市場成長に貢献する主な要因となっています。しかし、研究用抗体に対する品質の懸念、コスト・時間のかかる抗体開発プロセス、および有望企業が直面する価格圧力は、研究用抗体・試薬市場の大きな課題となっています。

当レポートでは、研究用抗体・試薬の世界市場に注目し、最新の動向、R&D活動、および新製品発売の動向、製品・技術・アプリケーション・エンドユーザー・地域別による収益性の高い新興市場に関する包括的な情報、および主要企業のプロファイルなどについて、まとめています。

FIGURE 14 RESEARCH ANTIBODIES AND REAGENTS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 研究用抗体・試薬:市場概要
  • 研究用抗体体・試薬市場:地域の成長機会
  • 地域ミックス:研究用抗体・試薬市場
  • 欧州:研究用抗体市場、研究領域別
  • 研究用抗体・試薬市場:先進諸国 vs. 新興諸国

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場成長促進要因
    • 市場機会
    • 主な課題

第6章 研究用抗体・試薬市場:製品別

  • イントロダクション
  • 試薬
    • 培地 & 血清
    • 染色剤 & 色素
    • 定着剤
    • 緩衝剤
    • 溶剤
    • 酵素
    • プローブ
    • その他の試薬
  • 抗体
    • 抗体:種類別
    • 抗体:ソース別
    • 抗体:研究領域別

第7章 研究用抗体・試薬市場:技術別

  • イントロダクション
  • ウエスタンブロッティング
  • フローケミストリー
  • 酵素結合免疫吸着測定法 (ELISA)
  • 免疫組織化学法
  • 免疫蛍光法 (IF)
  • 免疫沈降法
  • その他の技術

第8章 研究用抗体・試薬市場:アプリケーション別

  • イントロダクション
  • プロテオミクス
  • 創薬
  • ゲノミクス

第9章 研究用抗体・試薬市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 大学・研究機関
  • CRO (医薬品開発受託機関)

第10章 研究用抗体・試薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋 (APAC)
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合ベンチマーキング

第12章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK GROUP
  • ABCAM PLC
  • BECTON, DICKINSON AND COMPANY
  • CELL SIGNALING TECHNOLOGY, INC.
  • BIO-RAD LABORATORIES, INC.
  • F. HOFFMANN-LA ROCHE LTD
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • LONZA
  • GENSCRIPT
  • PERKINELMER, INC.
  • BIOLEGEND, INC.

第13章 付録

図表リスト

図表

LIST OF TABLES

  • TABLE 1: KEY MARKET DRIVERS: IMPACT ANALYSIS
  • TABLE 2: KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
  • TABLE 3: KEY MARKET CHALLENGES: IMPACT ANALYSIS
  • TABLE 4: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: GLOBAL RESEARCH REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: GLOBAL RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: GLOBAL RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: GLOBAL RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: GLOBAL RESEARCH REAGENTS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL RESEARCH ANTIBODIES MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL RESEARCH ANTIBODIES MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL RESEARCH ANTIBODIES MARKET FOR MICE, BY MICE, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL RESEARCH ANTIBODIES MARKET FOR RABBITS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: GLOBAL RESEARCH ANTIBODIES MARKET FOR OTHER SOURCES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 24: GLOBAL RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: GLOBAL RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: GLOBAL RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: GLOBAL RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: GLOBAL RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: GLOBAL RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 31: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 37: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS
  • TABLE 40: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 44: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 52: NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 53: NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 55: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 57: NIH BUDGET FOR VARIOUS DISCIPLINES IN FY 2015 AND FY 2016:
  • TABLE 58: U.S.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 59: U.S.: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: U.S.: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 61: U.S.: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 62: U.S.: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: U.S.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 64: U.S.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: U.S.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 69: CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 70: CANADA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 72: CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 75: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 76: EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 78: EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 79: EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 83: GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 84: GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 86: GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 87: GERMANY: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 89: GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 90: GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 91: U.K.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 92: U. K.: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 93: U.K.: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 94: U. K.: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 95: U. K.: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 96: U.K.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 97: U.K.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 98: U.K.: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 99: FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 100: FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 101: FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 102: FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 103: FRANCE: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 105: FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 106: FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 107: ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 108: ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 110: ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 111: ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 113: ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 114: ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 115: SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 116: SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 118: SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 119: SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 120: SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 121: SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 122: SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 123: ROE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 124: ROE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: ROE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 126: ROE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 127: ROE: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 128: ROE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 129: ROE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 130: ROE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 131: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 132: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 133: ASIA-PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 134: ASIA-PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 135: ASIA-PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 136: ASIA-PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 137: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 138: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 139: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 140: JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 141: JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 142: JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 143: JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 144: JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 145: JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 146: JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 147: JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 148: CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 149: CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 150: CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 151: CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 152: CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 153: CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 154: CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 155: CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 156: INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 157: INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 158: INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 159: INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 160: INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 161: INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 162: INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 163: INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 164: ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 165: ROAPAC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 166: ROAPAC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 167: ROAPAC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 168: ROAPAC: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 169: ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 170: ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 171: ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 172: LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 173: LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 174: LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 175: LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 176: LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 177: LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 178: LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 179: LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)
  • TABLE 180: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 181: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 182: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 183: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2015-2022 (USD MILLION)
  • TABLE 184: MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 185: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 186: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 187: MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: BOTTOM UP APPROACH
  • FIGURE 5: TOP DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: GLOBAL RESEARCH ANTIBODIES MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: GLOBAL RESEARCH REAGENTS MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 13: GEOGRAPHIC ANALYSIS: GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET
  • FIGURE 14: INCREASE IN R&D EXPENDITURE IN THE LIFE SCIENCES INDUSTRY-MAJOR FACTOR DRIVING THE GROWTH OF THE RESEARCH ANTIBODIES AND REAGENTS MARKET IN THE FORECAST PERIOD
  • FIGURE 15: THE U.S. DOMINATED THE GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET IN 2016
  • FIGURE 16: APAC TO REGISTER THE HIGHEST GROWTH RATE IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET FROM 2017 TO 2022
  • FIGURE 17: ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN RESEARCH ANTIBODIES MARKET IN 2016
  • FIGURE 18: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 19: RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: NUMBER OF PERSONALIZED MEDICINE PRODUCTS, 2008-2016
  • FIGURE 21: REAGENTS SEGMENT TO LEAD GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2017-2022 (USD MILLION)
  • FIGURE 22: WESTERN BLOTTING SEGMENT LED GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2017 (USD MILLION)
  • FIGURE 23: PROTEOMICS SEGMENT TO LEAD GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2017-2022 (USD MILLION)
  • FIGURE 24: APPLICATION OF ANTIBODIES IN THE DRUG DEVELOPMENT PROCESS
  • FIGURE 25: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO LEAD GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER, 2017-2022 (USD MILLION)
  • FIGURE 26: RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SNAPSHOT (2016)
  • FIGURE 27: NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
  • FIGURE 28: EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
  • FIGURE 30: GLOBAL RESEARCH ANTIBODIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 31: COMPETITIVE LEADERSHIP MAPPING (2017)
  • FIGURE 32: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 33: MERCK GROUP: COMPANY SNAPSHOT (2016)
  • FIGURE 34: ABCAM PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 35: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 36: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 37: F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2016)
  • FIGURE 38: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 39: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 40: LONZA: COMPANY SNAPSHOT (2016)
  • FIGURE 41: GENSCRIPT: COMPANY SNAPSHOT (2016)
  • FIGURE 42: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
目次
Product Code: BT 5482

"The global research antibodies market (including reagents) is projected to grow at a CAGR of 6.2%."

The research antibodies market (including reagents) is estimated to grow at a CAGR of 6.2% from 2017 to 2022, to reach USD 12.60 billion by 2022 from USD 9.33 billion in 2017. The increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research & drug discovery, and growing collaboration between industries and academic institutes are the major factors responsible for the growth of the market during the forecast period. However, the quality concerns over research antibodies (with respect to research reproducibility), cost- and time- intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.

"The antibodies segment is expected to grow at the fastest rate during the forecast period."

By product, the research antibodies market (including reagents) is segmented into antibodies and reagents. The research antibodies segment is expected to register the highest CAGR during the forecast period owing to their high sensitivity, specificity, and affinity in various research reactions. Also, they are majorly used in proteomic research and drug development for identification, regulatory characterization, and discovery.

"The pharmaceutical and biotechnological companies segment is expected to grow at the fastest rate during the forecast period."

On the basis of end user, the research antibodies market is segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnological companies segment is expected to grow at the highest CAGR during the forecast period. This is primarily due to the increasing research in the fields of genomics and proteomics and the high uptake of research-specific antibodies in the drug discovery and development process.

"APAC to witness the highest growth during the forecast period."

Geographically, the global research antibodies market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2016, North America commanded a major share of the research antibodies market. However, Asia-Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia-Pacific market is mainly attributed to the growing proteomics and genomics research & increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.

Some of the prominent players in the research antibodies and reagents market include Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).

Research Coverage:

The report analyzes the various types of research antibodies and reagents in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the research antibodies market for different segments such as product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies for strengthening their market position.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the research antibodies market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the research antibodies market
  • Market Development: Comprehensive information about lucrative emerging markets by product, technology, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the research antibodies market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the research antibodies market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS
  • 1.6. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY RESEARCH
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Break down of primaries
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. RESEARCH ANTIBODIES AND REAGENTS: MARKET OVERVIEW
  • 4.2. RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.3. REGIONAL MIX: RESEARCH ANTIBODIES AND REAGENTS MARKET
  • 4.4. EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA
  • 4.5. RESEARCH ANTIBODIES AND REAGENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Increasing research activity, funding for R&D
      • 5.2.1.2. Growing industry-academia collaborations
    • 5.2.2. KEY MARKET OPPORTUNITIES
      • 5.2.2.1. High growth opportunities in emerging markets
      • 5.2.2.2. Increasing demand for personalized medicine and protein therapeutics
      • 5.2.2.3. Growth in stem cell and neurobiology research
      • 5.2.2.4. Increasing focus on biomarker discovery
    • 5.2.3. KEY CHALLENGES
      • 5.2.3.1. Quality concerns over research antibodies
      • 5.2.3.2. Cost- and time-intensive antibody development processes
      • 5.2.3.3. Pricing pressure faced by prominent market players

6. GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS
    • 6.2.1. MEDIA & SERA
    • 6.2.2. STAINS & DYES
    • 6.2.3. FIXATIVES
    • 6.2.4. BUFFERS
    • 6.2.5. SOLVENTS
    • 6.2.6. ENZYMES
    • 6.2.7. PROBES
    • 6.2.8. OTHER REAGENTS
  • 6.3. ANTIBODIES
    • 6.3.1. ANTIBODIES, BY TYPE
      • 6.3.1.1. Primary antibodies
      • 6.3.1.2. Secondary antibodies
    • 6.3.2. ANTIBODIES, BY SOURCE
      • 6.3.2.1. Mice
      • 6.3.2.2. Rabbits
      • 6.3.2.3. Other sources
    • 6.3.3. ANTIBODIES, BY RESEARCH AREA
      • 6.3.3.1. Oncology
      • 6.3.3.2. Infectious diseases
      • 6.3.3.3. Immunology
      • 6.3.3.4. Neurobiology
      • 6.3.3.5. Stem cells
      • 6.3.3.6. Other research areas

7. GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. WESTERN BLOTTING
  • 7.3. FLOW CYTOMETRY
  • 7.4. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
  • 7.5. IMMUNOHISTOCHEMISTRY
  • 7.6. IMMUNOFLUORESCENCE
  • 7.7. IMMUNOPRECIPITATION
  • 7.8. OTHER TECHNOLOGIES

8. GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. PROTEOMICS
  • 8.3. DRUG DEVELOPMENT
  • 8.4. GENOMICS

9. GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END-USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3. ACADEMIC & RESEARCH INSTITUTES
  • 9.4. CONTRACT RESEARCH ORGANIZATIONS

10. GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
    • 11.4.2. BUSINESS STRATEGIES EXCELLENCE (FOR 25 PLAYERS)

12. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 12.1. THERMO FISHER SCIENTIFIC INC.
  • 12.2. MERCK GROUP
  • 12.3. ABCAM PLC
  • 12.4. BECTON, DICKINSON AND COMPANY
  • 12.5. CELL SIGNALING TECHNOLOGY, INC.
  • 12.6. BIO-RAD LABORATORIES, INC.
  • 12.7. F. HOFFMANN-LA ROCHE LTD
  • 12.8. AGILENT TECHNOLOGIES, INC.
  • 12.9. DANAHER CORPORATION
  • 12.10. LONZA
  • 12.11. GENSCRIPT
  • 12.12. PERKINELMER, INC.
  • 12.13. BIOLEGEND, INC.

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS
Back to Top